Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cardio-protective Effect of Metformin in Patients Undergoing Elective Percutaneous Coronary Intervention

NCT05708053 is registered in ClinicalTrials.gov with Future University in Egypt as lead sponsor.

NCT NCT05708053
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05708053 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cardio-protective Effect of Metformin in Patients Undergoing Elective Percutaneous Coronary Intervention
Lead sponsor
Future University in Egypt
Phase
Phase 3
Overall status
Completed
Start date
December 9, 2019
Completion date
December 30, 2021
Enrollment
80 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

elective percutaneous coronary intervention, ischemic reperfusion injury